E
Adverum Biotechnologies, Inc. ADVM
$3.08 $0.051.65% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -49.19M -47.02M -60.53M -27.13M -30.50M
Total Depreciation and Amortization 535.00K 683.00K 810.00K 890.00K 956.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2.40M 3.35M 22.54M 3.01M 7.72M
Change in Net Operating Assets 7.49M 215.00K 8.93M 2.11M 1.98M
Cash from Operations -38.77M -42.77M -28.25M -21.12M -19.84M
Capital Expenditure -120.00K -220.00K -61.00K -221.00K -16.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 32.02M 31.50M -4.13M -13.13M -2.31M
Cash from Investing 31.90M 31.28M -4.19M -13.35M -2.33M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 120.00K -- 239.00K 0.00 --
Repurchase of Common Stock -- -- -- -- -116.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 120.00K -- 239.00K 0.00 -116.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -6.74M -11.49M -32.20M -34.47M -22.29M